Designing of novel ERRγ inverse agonists by molecular modeling studies of docking and 3D-QSAR on hydroxytamoxifen derivatives

  • Rui Li
  • Yongli DuEmail author
  • Jingkang Shen
Original Research


ERRγinverse agonist is a powerful therapeutic target for the treatment of cancers and certain metabolic disorders. Until now, only GSK5814 was reported as selective ERRγinverse agonist. So 60 newly hydroxytamoxifen analogues were selected to perform molecular docking and 3D-QSAR study to design more selective inverse agonist of ERRγ. Both established CoMFA and CoMSIA models obtained high predictive and satisfactory value, demonstrated that bulky, hydrophobic and negative electrostatic substitutions are preferred at R2 position, and introducing hydrophilic and H-bond donor and acceptor groups at R1 and R4 positions is greatly important for improving binding activities. The obtained information will be useful to provide clues for rationally designing novel and high potency ERRγinverse agonists.


ERRγinverse agonist Molecular docking 3D-QSAR CoMFA CoMSIA 



This work were supported by a grant from the National Natural Science Foundation of China (81872744) and Shandong Natural Science Foundation of China (ZR2019MH046).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Aalizadeh R, Pourbasheer E, Ganjali MR (2015) Analysis of B-Raf inhibitors using 2D and 3D-QSAR, molecular docking and pharmacophore studies. Mol Divers 19:915–930CrossRefGoogle Scholar
  2. Abad MC, Askari H, O’Neill J, Klinger AL, Milligan C, Lewandowski F, Springer B, Spurlino J, Rentzeperis D (2008) Structural determination of estrogen-related receptor γ in the presence of phenol derivative compounds. J Steroid Biochem 108:44–54CrossRefGoogle Scholar
  3. Balasubramanian PK, Balupuri A, Gadhe CG, Cho SJ (2014) 3D QSAR modeling study on 7-aminofuro [2, 3-c] pyridine derivatives as TAK1 inhibitors using CoMFA and COMSIA. Med Chem Res 24:2347–2365CrossRefGoogle Scholar
  4. Clark M, Cramer RD, Van Opdenbosch N (1989) Validation of the general purpose tripos 5.2 force field. J Comput Chem 10:982–1012CrossRefGoogle Scholar
  5. Cleves AE, Jain AN (2006) Robust ligand-based modeling of the biological targets of known drugs. J Med Chem 49:2921–2938CrossRefGoogle Scholar
  6. Coward P, Lee D, Hull MV, Lehmann JM (2001) 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Proc Natl Acad Sci USA 98:8880–8884CrossRefGoogle Scholar
  7. Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967Google Scholar
  8. Cramer RD, Patterson DE, Bunce JD (1989) Recent advances in comparative molecular field analysis (CoMFA). Progre Clini Biolo Res 291:161–165.Google Scholar
  9. Giguére V (2002) To ERR in the estrogen pathway. Trends Endocrin Met 13:220–225CrossRefGoogle Scholar
  10. Greschik H, Wurtz JM, Sanglier S, Bourguet W, van Dorsselaer A, Moras D, Renaud JP (2002) Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol Cell 9:303–313CrossRefGoogle Scholar
  11. Horard B (2003) Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J Mol Endocrinol 31:349–357CrossRefGoogle Scholar
  12. Jung YS, Lee JM, Kim DK, Lee YS, Kim KS, Kim YH, Kim J, Lee MS, Lee IK, Kim SH, Cho SJ, Jeong WI, Lee CH, Harris RA, Choi HS (2016) The orphan nuclear receptor ERRgamma regulates hepatic cb1 receptor-mediated fibroblast growth factor 21 gene expression. PloS one 11:e0159425CrossRefGoogle Scholar
  13. Kallen J, Schlaeppi JM, Bitsch F, Filipuzzi I, Schilb A, Riou V, Graham A, Strauss A, Geiser M, Fournier B, Fournier B (2004) Evidence for ligand-independent Transcriptional Activation of the Human Estrogen-related Receptor α (ERRα). J BIOL CHEM 279:49330–49337CrossRefGoogle Scholar
  14. Kim DK, Kim JR, Koh M, Kim YD, Lee JM, Chanda D, Park SB, Min JJ, Lee CH, Park TS, Choi HS (2011) Estrogen-related receptor gamma (ERRgamma) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling. J Biol Chem 286:38035–38042Google Scholar
  15. Kim J, Chin J, Im CY, Yoo EK, Woo S, Hwang HJ, Jh Cho, Ka Seo, Song J, Hwang H, Kim KH, Kim ND, Yoon SK, Jeon JH, Yoon SY, Jeon YH, Choi HS, Lee IK, Kim SH, Cho SJ (2016) Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists. Eur J Med Chem 120:338–352CrossRefGoogle Scholar
  16. Kim J, Woo SY, Im CY, Yoo EK, Lee S, Kim H-J, Cho JH, Lee WS, Yoon H, Kim S, Kwon OB, Hwang H, Kim KH, Jeon JH, Singh TD, Kim SW, Hwang SY, Choi HS, Lee IK, Kim SH, Jeon YH, Chin J, Cho SJ (2016) Insights of a lead optimization study and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor γ (ERRγ) Inverse Agonists. J Med Chem 59:10209–10227CrossRefGoogle Scholar
  17. Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37: 4130–4146Google Scholar
  18. Lin H, Doebelin C, Patouret R, Garcia-Ordonez RD, Chang MR, Dharmarajan V, Bayona CR, Cameron MD, Griffin PR, Kamenecka TM (2017) Design, synthesis, and evaluation of simple phenol amides as ERRgamma agonists. Bioorg Med Chem Lett 28:1313–1319CrossRefGoogle Scholar
  19. Nam K, Marshall PM, Wolf R, Cornell W (2002) Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor α and estrogen-related receptor γ. Biopolymers 68:130–138CrossRefGoogle Scholar
  20. Narkar VA, Fan W, Downes M, Yu RT, Jonker JW, Alaynick WA, Banayo E, Karunasiri MS, Lorca S, Evans RM (2011) Exercise and PGC-1alpha-independent synchronization of type I muscle metabolism and vasculature by ERRgamma. Cell Metab 13:283–293CrossRefGoogle Scholar
  21. Ron Wehrens HP, Lutgarde MC, Buydens (2000) The bootstrap: a tutorial. Chemom Intell Lab 54:35–52CrossRefGoogle Scholar
  22. Wang L, Zuercher WJ, Consler TG, Lambert MH, Miller AB, Orband-Miller LA, McKee DD, Willson TM, Nolte RT (2006) X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation. J Biol Chem 281:37773–37781CrossRefGoogle Scholar
  23. Wold S, Ruhe A, Wold H, Dunn III WJ (1984) The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses. Siam J Sci Stat Comput 5:735–743CrossRefGoogle Scholar
  24. Yu DD, Forman BM (2005) Identification of an agonist ligand for estrogen-related receptors ERRβ/γ. BIOORG MED CHEM LETT 15:1311–1313CrossRefGoogle Scholar
  25. Yu DD, Huss JM, Li H, Forman BM (2017) Identification of novel inverse agonists of estrogen-related receptors ERRγ and ERRβ. Bioorg Med Chem Lett 25:1585–1599CrossRefGoogle Scholar
  26. Zhang Y, Kim DK, Lee JM, Park SB, Jeong WI, Kim SH, Lee IK, Lee CH, Chiang JY, Choi HS (2015) Orphan nuclear receptor oestrogen-related receptor gamma (ERRgamma) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression. Biochem J 470:181–193Google Scholar
  27. Zuercher WJ, Gaillard S, Orband-Miller LA, Chao EYH, Shearer BG, Jones DG, Miller AB, Collins JL, McDonnell DP, Willson TM (2005) Identification and structure−activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRβ and ERRγ. J Med Chem 48:3107–3109CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.School of Chemistry and Pharmaceutical EngineeringQilu University of Technology (Shandong Academy of Sciences)JinanChina
  2. 2.State Key Laboratory of Drug Research, Shanghai Institute of Materia MedicaChinese Academy of SciencesShanghaiChina

Personalised recommendations